Galecto Inc
GLTOGalecto Inc. is a clinical stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets which are at the heart of fibrosis, inflammation and cancer. The company was founded by leading fibrosis-focused scientists and biotech executives a …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at Galecto Inc
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 1/3/2025 | Sell | Schambye, Hans T. | Chief Executive Officer | $5.6 | $7,510 |
| 1/3/2025 | Sell | Firmani, Lori | Interim CFO | $5.6 | $1,469 |
| 1/3/2025 | Sell | Winslow, Garrett | General Counsel | $5.6 | $2,638 |
| 8/15/2023 | Sell | Orbimed Advisors LLC | Ten Percent Owner | $0.8 | $617,010 |
| 7/31/2023 | Sell | Orbimed Advisors LLC | Ten Percent Owner | $3.0 | $628,200 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)